Search

everythinglearnresearchcommunity

for

Search:↓

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Hair loss may indicate higher risk of heart disease.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Low-cost dermoscopes can effectively diagnose early female pattern hair loss.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Taking oral vitamin D and applying topical minoxidil together can better treat female pattern hair loss than using either treatment alone.

Micrografts are a safe and effective treatment for hair loss in both men and women.

Acne severity is not related to the type or severity of androgenetic alopecia.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

Genetic factors could lead to personalized treatments for hair loss.

The combined treatment improved scalp health in women with early-stage hair loss.

Minoxidil helps hair growth but has side effects.

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

The treatment might help COVID-19 related hair loss, but more research is needed.

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

High-frequency ultrasound can effectively visualize and assess hair loss.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

AC5 improves hair loss and hair quality with high satisfaction rates.